Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
fda
6
×
indiana blog main
indiana top stories
6
×
life sciences
national blog main
eli lilly
amgen
boston blog main
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
teva pharmaceutical
boston top stories
boulder/denver blog main
boulder/denver top stories
calcitonin gene-related peptide
chronic migraine
detroit blog main
detroit top stories
migraine research foundation
national top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
drugs
episodic migraine
eptinezumab
erenumab
fremanezumab
galcanezumab
What
approval
6
×
drug
6
×
fda
won
migraine
new
class
developed
eli
lilly
approved
decades
friday
late
medicines
oral
pain
starts
acute
addresses
agency
aimmune
allergy
amgen
announced
arguments
awarded
bid
big
boehringer
candidates
causes
commercialized
companies
competitors
condition
decision
diabetes
drugs
expand
Language
unset
Current search:
drug
×
fda
×
" indiana top stories "
×
approval
×
@xconomy.com
4 years ago
FDA Rejects Boehringer Ingelheim, Eli Lilly Drug for Type 1 Diabetes
@xconomy.com
4 years ago
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy
@xconomy.com
4 years ago
FDA OKs Lilly’s Lasmiditan, First New Acute Migraine Drug in Decades
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments
@xconomy.com
5 years ago
Eli Lilly Migraine Drug Approved, the Third in New Class of Medicines
@xconomy.com
6 years ago
Amgen Migraine Drug Gets FDA Nod, First in New Class of Medicines